-
The effect of nurses' communication skills with Nulliparous mothers on exclusive breastfeeding: A Clinical Trial Study
Mamak Shariat, Nasrin Abedinia, Fedyeh Haghollahi, Ahmad Ali Noorbala, Akram Karimi and Jayran Zebardast
Research Article: Clinical Investigation
-
The effect of nurses' communication skills with Nulliparous mothers on exclusive breastfeeding: A Clinical Trial Study
Mamak Shariat, Nasrin Abedinia, Fedyeh Haghollahi, Ahmad Ali Noorbala, Akram Karimi and Jayran Zebardast
Research Article: Clinical Investigation
-
The effect of nurses' communication skills with Nulliparous mothers on exclusive breastfeeding: A Clinical Trial Study
Mamak Shariat, Nasrin Abedinia, Fedyeh Haghollahi, Ahmad Ali Noorbala, Akram Karimi and Jayran Zebardast
Research Article: Clinical Investigation
-
The effect of nurses' communication skills with Nulliparous mothers on exclusive breastfeeding: A Clinical Trial Study
Mamak Shariat, Nasrin Abedinia, Fedyeh Haghollahi, Ahmad Ali Noorbala, Akram Karimi and Jayran Zebardast
Research Article: Clinical Investigation
-
The effect of nurses' communication skills with Nulliparous mothers on exclusive breastfeeding: A Clinical Trial Study
Mamak Shariat, Nasrin Abedinia, Fedyeh Haghollahi, Ahmad Ali Noorbala, Akram Karimi and Jayran Zebardast
Research Article: Clinical Investigation
-
The effect of nurses' communication skills with Nulliparous mothers on exclusive breastfeeding: A Clinical Trial Study
Mamak Shariat, Nasrin Abedinia, Fedyeh Haghollahi, Ahmad Ali Noorbala, Akram Karimi and Jayran Zebardast
Research Article: Clinical Investigation
-
The effect of nurses' communication skills with Nulliparous mothers on exclusive breastfeeding: A Clinical Trial Study
Mamak Shariat, Nasrin Abedinia, Fedyeh Haghollahi, Ahmad Ali Noorbala, Akram Karimi and Jayran Zebardast
Research Article: Clinical Investigation
-
The effect of nurses' communication skills with Nulliparous mothers on exclusive breastfeeding: A Clinical Trial Study
Mamak Shariat, Nasrin Abedinia, Fedyeh Haghollahi, Ahmad Ali Noorbala, Akram Karimi and Jayran Zebardast
Research Article: Clinical Investigation
-
The Big Ten Cancer Research Consortium: teaming up to fight cancer
Susan Goodin, Robert S DiPaola & Patrick J Loehrer
Research Update: Clinical Investigation
-
The Big Ten Cancer Research Consortium: teaming up to fight cancer
Susan Goodin, Robert S DiPaola & Patrick J Loehrer
Research Update: Clinical Investigation
-
The Big Ten Cancer Research Consortium: teaming up to fight cancer
Susan Goodin, Robert S DiPaola & Patrick J Loehrer
Research Update: Clinical Investigation
-
The Big Ten Cancer Research Consortium: teaming up to fight cancer
Susan Goodin, Robert S DiPaola & Patrick J Loehrer
Research Update: Clinical Investigation
-
The Big Ten Cancer Research Consortium: teaming up to fight cancer
Susan Goodin, Robert S DiPaola & Patrick J Loehrer
Research Update: Clinical Investigation
-
The Big Ten Cancer Research Consortium: teaming up to fight cancer
Susan Goodin, Robert S DiPaola & Patrick J Loehrer
Research Update: Clinical Investigation
-
The Big Ten Cancer Research Consortium: teaming up to fight cancer
Susan Goodin, Robert S DiPaola & Patrick J Loehrer
Research Update: Clinical Investigation
-
The Big Ten Cancer Research Consortium: teaming up to fight cancer
Susan Goodin, Robert S DiPaola & Patrick J Loehrer
Research Update: Clinical Investigation
-
Linaclotide for irritable bowel syndrome with constipation: a review
Michael Arriaga & Eamonn MM Quigley
Drug Evaluation: Clinical Investigation
-
Linaclotide for irritable bowel syndrome with constipation: a review
Michael Arriaga & Eamonn MM Quigley
Drug Evaluation: Clinical Investigation
-
Linaclotide for irritable bowel syndrome with constipation: a review
Michael Arriaga & Eamonn MM Quigley
Drug Evaluation: Clinical Investigation
-
Linaclotide for irritable bowel syndrome with constipation: a review
Michael Arriaga & Eamonn MM Quigley
Drug Evaluation: Clinical Investigation
-
Linaclotide for irritable bowel syndrome with constipation: a review
Michael Arriaga & Eamonn MM Quigley
Drug Evaluation: Clinical Investigation
-
Linaclotide for irritable bowel syndrome with constipation: a review
Michael Arriaga & Eamonn MM Quigley
Drug Evaluation: Clinical Investigation
-
Linaclotide for irritable bowel syndrome with constipation: a review
Michael Arriaga & Eamonn MM Quigley
Drug Evaluation: Clinical Investigation
-
Linaclotide for irritable bowel syndrome with constipation: a review
Michael Arriaga & Eamonn MM Quigley
Drug Evaluation: Clinical Investigation
-
Eratum: Clin Invest (2014) 4(2), 227-234.
Erratum: Clinical Investigation
-
Eratum: Clin Invest (2014) 4(2), 227-234.
Erratum: Clinical Investigation
-
Eratum: Clin Invest (2014) 4(2), 227-234.
Erratum: Clinical Investigation
-
Eratum: Clin Invest (2014) 4(2), 227-234.
Erratum: Clinical Investigation
-
Eratum: Clin Invest (2014) 4(2), 227-234.
Erratum: Clinical Investigation
-
Eratum: Clin Invest (2014) 4(2), 227-234.
Erratum: Clinical Investigation
-
Eratum: Clin Invest (2014) 4(2), 227-234.
Erratum: Clinical Investigation
-
Eratum: Clin Invest (2014) 4(2), 227-234.
Erratum: Clinical Investigation
-
Dulaglutide: a novel once-weekly glucagon-like peptide-1 receptor agonist
Signe V Naver, Espen Jimenez-Solem, Mikkel Christensen, Jon T Andersen & Filip K Knop
Clinical Trail Outcomes: Clinical Investigation
-
Dulaglutide: a novel once-weekly glucagon-like peptide-1 receptor agonist
Signe V Naver, Espen Jimenez-Solem, Mikkel Christensen, Jon T Andersen & Filip K Knop
Clinical Trail Outcomes: Clinical Investigation
-
Dulaglutide: a novel once-weekly glucagon-like peptide-1 receptor agonist
Signe V Naver, Espen Jimenez-Solem, Mikkel Christensen, Jon T Andersen & Filip K Knop
Clinical Trail Outcomes: Clinical Investigation
-
Dulaglutide: a novel once-weekly glucagon-like peptide-1 receptor agonist
Signe V Naver, Espen Jimenez-Solem, Mikkel Christensen, Jon T Andersen & Filip K Knop
Clinical Trail Outcomes: Clinical Investigation
-
Dulaglutide: a novel once-weekly glucagon-like peptide-1 receptor agonist
Signe V Naver, Espen Jimenez-Solem, Mikkel Christensen, Jon T Andersen & Filip K Knop
Clinical Trail Outcomes: Clinical Investigation
-
Dulaglutide: a novel once-weekly glucagon-like peptide-1 receptor agonist
Signe V Naver, Espen Jimenez-Solem, Mikkel Christensen, Jon T Andersen & Filip K Knop
Clinical Trail Outcomes: Clinical Investigation
-
Dulaglutide: a novel once-weekly glucagon-like peptide-1 receptor agonist
Signe V Naver, Espen Jimenez-Solem, Mikkel Christensen, Jon T Andersen & Filip K Knop
Clinical Trail Outcomes: Clinical Investigation
-
Dulaglutide: a novel once-weekly glucagon-like peptide-1 receptor agonist
Signe V Naver, Espen Jimenez-Solem, Mikkel Christensen, Jon T Andersen & Filip K Knop
Clinical Trail Outcomes: Clinical Investigation